Abstract:Objective: To investigate the possible role of miR1271 in the development of cisplatin resistance in human ovarian cancer cell line SKOV3/DDP. Methods: Using quantitative realtime PCR analysis for miRNA and Western blotting to detect the expression difference of miR1271 and Xlinked inhibitor of apoptosis protein(XIAP) between cisplatinresistant human ovarian cancer cell line SKOV3/DDP and its parental SKOV3 cell line, respectively. Constructing XIAP 3′untranslated regionbased luciferase reporter plasmids to verify the target gene of miR1271. Transient transfection of miR1271 mimic was used to upregulate the expression level of miR1271 in SKOV3/DDP cells and observe the effect of miR1271 on the expression level of XIAP and the cisplatin resistance phenotype. Flow cytometry was used to detect cisplatininduced apoptosis of SKOV3/DDP cells after the transfection. Results: miR1271 was downregulated in cisplatinresistant human ovarian cancer cell line SKOV3/DDP, which was concurrent with the overexpression of its target antiapoptotic gene XIAP in SKOV3/DDP cells, compared with the parental SKOV3 cell line. The luciferase activity of XIAP 3′untranslated regionbased reporters construct in SKOV3/DDP cells suggested that XIAP was the direct target gene of the miR1271. Overexpression of miR1271 sensitized SKOV3/DDP cells to cisplatin, inhibited the expression level of XIAP and sensitized SKOV3/DDP cells to DDPinduced apoptosis. Conclusion: miR1271 may play a role in the development of cisplatin resistance in human ovarian cancer cell line, at least in part, by modulation of apoptosis via targeting XIAP.
收稿日期: 2017-02-03
通讯作者:
陈建国(通讯作者),主任技师,硕士生导师,E-mail: cjg02@126.com
引用本文:
王广洲1, 2, 秦闫燕1, 卢洁1, 苏兆亮1, 朱伟3, 陈建国4. miR-1271对卵巢癌SKOV3/DDP细胞顺铂耐药的影响及其机制[J]. 江苏大学学报:医学版, 2017, 27(02): 118-122.
WANG Guang-zhou1,2, QIN Yan-yan1, LU Jie1, SU Zhao-liang1, ZHU Wei3, CHEN Jian-guo4. Effect of miR-1271 on cisplatin resistance in human ovarian cancer cell line SKOV3/DDP and its potential mechanism. Journal of Jiangsu University(Medicine Edition), 2017, 27(02): 118-122.
[1\]Du Y, Zhu M, Zhou X, et al. miR20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB\[J\]. Tumour Biol, 2016, 37 (1): 1261-1269.\[2\]Zhu W, Shan X, Wang T, et al. miR181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines\[J\]. Int J Cancer, 2010, 127 (11): 2520-2529.\[3\]陈复辉, 曲宏岩, 隋广杰. 凋亡抑制蛋白XIAP基因对A549细胞凋亡和化疗敏感性的影响\[J\]. 中国肺癌杂志, 2008, 11(3): 368-372.\[4\]Lippert TH, Ruoff HJ, Volm M. Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure\[J\]. Arzneimittelforschung, 2008, 58(6): 261-264.\[5\]Sharma SV, Lee DY, Li B, et al. A chromatinmediated reversible drugtolerant state in cancer cell subpopulations\[J\]. Cell, 2010, 141(1): 69-80.\[6\]智慧, 朱伟, 王同彬, 等. miR125b靶向抑制BCL2、MCL1表达对胃癌SGC7901/VCR细胞多药耐药性的影响\[J\]. 南京医科大学学报(自然科学版), 2011, 31(6): 777-782.\[7\]房栋, 徐静, 朱伟, 等. miR181a/b靶向抑制多种抗凋亡蛋白表达对肺癌细胞顺铂耐药的影响\[J\]. 南京医科大学学报(自然科学版), 2012, 32(12): 1690-1695.\[8\]Morin RD, O′Connor MD, Griffith M, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells\[J\]. Genome Res, 2008, 18(4): 610-621.\[9\]Jensen KP, Covault J. Human miR1271 is a miR96 paralog with distinct nonconserved brain expression pattern\[J\]. Nucleic Acids Res, 2011, 39(2): 701-711.\[10\]Liu H, Wang H, Liu X, et al. miR1271 inhibits migration, invasion and epithelialmesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells\[J\]. Biochem Biophys Res Commun, 2016, 472(2): 346-352.\[11\]Zhou Z, Niu X, Li C, et al. Inhibition of the growth of nonsmall cell lung cancer by miRNA1271\[J\]. Am J Transl Res, 2015, 7(10): 1917-1924.\[12\]Liu X, Ma L, Rao Q, et al. miR1271 inhibits ovarian cancer growth by targeting cyclin G1\[J\]. Med Sci Monit, 2015, 21: 3152-3158.\[13\]Xiang XJ, Deng J, Liu YW, et al. miR1271 inhibits cell proliferation, invasion and EMT in gastric cancer by targeting FOXQ1\[J\]. Cell Physiol Biochem, 2015, 36(4): 1382-1394.\[14\]Yang M, Shan X, Zhou X, et al. miR1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2\[J\]. Anticancer Agents Med Chem, 2014, 14(6): 884-891.